全文获取类型
收费全文 | 46篇 |
免费 | 5篇 |
专业分类
基础医学 | 11篇 |
临床医学 | 2篇 |
内科学 | 20篇 |
神经病学 | 2篇 |
外科学 | 5篇 |
综合类 | 4篇 |
预防医学 | 7篇 |
出版年
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 2篇 |
2019年 | 3篇 |
2016年 | 3篇 |
2015年 | 2篇 |
2014年 | 2篇 |
2013年 | 2篇 |
2012年 | 6篇 |
2011年 | 3篇 |
2010年 | 1篇 |
2009年 | 1篇 |
2007年 | 2篇 |
2006年 | 4篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2002年 | 1篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1996年 | 1篇 |
1995年 | 3篇 |
1994年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1981年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有51条查询结果,搜索用时 15 毫秒
1.
Chege GK Snodgrass DR Campbell I Hart C Omollo E Mwenda JM 《African journal of health sciences》1995,2(2):296-299
A total of 51 monkeys maintained in a colony at the Institute of Primate Research (Kenya) and housed in doors with natural lighting in a group cage were used in this study. Monkeys belonging to 3 species were selected at random and blood samples collected. The serum samples were screened for presence of neutralizing antibodies (VTN) to rhesus rotavirus (RRV) by virus neutralization assay. Virus neutralization was determined by 60% reduction in fluorescent focus units (ffu). 96% of the animals screened had naturally occurring antibodies to rhesus rotavirus. Another group of 11 lactating monkeys (5 baboons, 6 vervets) and their infants were screened further for presence of IgG and IgA antibodies in serum and breast milk (mothers). Overall, the mothers had higher titres of both IgG and IgA than the infants. Taken together, these results demonstrate rotavirus infection is endemic in this primate colony. This mimics the human situation, hence, captive non human primates (such as the baboons) could be a suitable model for testing rotavirus candidate vaccines and for investigating the possible application in humans of passive-active immunization strategy. 相似文献
2.
3.
4.
5.
Burgers WA Manrique A Masopust D McKinnon LR Reynolds MR Rolland M Blish C Chege GK Curran R Fischer W Herrera C Sather DN 《AIDS research and human retroviruses》2012,28(7):641-648
Well-defined correlates of protective immunity are an essential component of rational vaccine development. Despite years of basic science and three HIV vaccine efficacy trials, correlates of immunological protection from HIV infection remain undefined. In December 2010, a meeting of scientists engaged in basic and translational work toward developing HIV-1 vaccines was convened. The goal of this meeting was to discuss current opportunities and optimal approaches for defining correlates of protection, both for ongoing and future HIV-1 vaccine candidates; specific efforts were made to engage young scientists. We discuss here the highlights from the meeting regarding the progress made and the way forward for a protective HIV-1 vaccine. 相似文献
6.
Gerald K. Chege Craig H. Adams Alana T. Keyser Valerie Bekker Lynn Morris Francois J. Villinger Anna-Lise Williamson Rosamund E. Chapman 《Viruses》2021,13(3)
Rhesus macaques can be readily infected with chimeric simian-human immunodeficiency viruses (SHIV) as a suitable virus challenge system for testing the efficacy of HIV vaccines. Three Chinese-origin rhesus macaques (ChRM) were inoculated intravenously (IV) with SHIVC109P4 in a rapid serial in vivo passage. SHIV recovered from the peripheral blood of the final ChRM was used to generate a ChRM-adapted virus challenge stock. This stock was titrated for the intrarectal route (IR) in 8 ChRMs using undiluted, 1:10 or 1:100 dilutions, to determine a suitable dose for use in future vaccine efficacy testing via repeated low-dose IR challenges. All 11 ChRMs were successfully infected, reaching similar median peak viraemias at 1–2 weeks post inoculation but undetectable levels by 8 weeks post inoculation. T-cell responses were detected in all animals and Tier 1 neutralizing antibodies (Nab) developed in 10 of 11 infected ChRMs. All ChRMs remained healthy and maintained normal CD4+ T cell counts. Sequence analyses showed >98% amino acid identity between the original inoculum and virus recovered at peak viraemia indicating only minimal changes in the env gene. Thus, while replication is limited over time, our adapted SHIV can be used to test for protection of virus acquisition in ChRMs. 相似文献
7.
8.
9.
Gerald K. Chege Robin Thomas Enid G. Shephard Ann Meyers William Bourn Carolyn Williamson James Maclean Clive M. Gray Edward P. Rybicki Anna-Lise Williamson 《Vaccine》2009
Mycobacterium bovis BCG is considered an attractive live bacterial vaccine vector. In this study, we investigated the immune response of baboons to a primary vaccination with recombinant BCG (rBCG) constructs expressing the gag gene from a South African HIV-1 subtype C isolate, and a boost with HIV-1 subtype C Pr55gag virus-like particles (Gag VLPs). Using an interferon enzyme-linked immunospot assay, we show that although these rBCG induced only a weak or an undetectable HIV-1 Gag-specific response on their own, they efficiently primed for a Gag VLP boost, which strengthened and broadened the immune responses. These responses were predominantly CD8+ T cell-mediated and recognised similar epitopes as those targeted by humans with early HIV-1 subtype C infection. In addition, a Gag-specific humoral response was elicited. These data support the development of HIV-1 vaccines based on rBCG and Pr55gag VLPs. 相似文献
10.
Rota J Lowe L Rota P Bellini W Redd S Dayan G van Binnendijk R Hahné S Tipples G Macey J Espinoza R Posey D Plummer A Bateman J Gudiño J Cruz-Ramirez E Lopez-Martinez I Anaya-Lopez L Holy Akwar T Giffin S Carrión V de Filippis AM Vicari A Tan C Wolf B Wytovich K Borus P Mbugua F Chege P Kombich J Akoua-Koffi C Smit S Bukenya H Bwogi J Baliraine FN Kremer J Muller C Santibanez S 《Emerging infectious diseases》2006,12(11):1779-1781
Surveillance of measles virus detected an epidemiologic link between a refugee from Kenya and a Dutch tourist in New Jersey, USA. Identical genotype B3 sequences from patients with contemporaneous cases in the United States, Canada, and Mexico in November and December 2005 indicate that Kenya was likely to have been the common source of virus. 相似文献